|
Index of reports
> Cases with Diarrhoea (149)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 149 Next >>
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Neurogenic Bladder, Neuropathy Peripheral, Syncope, Diarrhoea, Interstitial Lung Disease, Dizziness, Toxic Skin Eruption, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Piperacillin Tazobactam
Indication: Infection
Velcade
Dosage: 2.4 mg, unk
Indication: Multiple Myeloma
Start date: 2011-11-14
End date: 2011-11-24
Other drugs received by patient: Mecobalamin; Lansoprazole; Uralyt / 01779901 /; Goshajinkigan; Acecol; Olopatadine HCL; Oxinorm / 00547301 /; Dexamethasone; Losartan Potassium
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: male
Reactions: Neuropathy Peripheral, Diarrhoea, Visual Acuity Reduced, Constipation
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in 71 year old male
Reported by a physician from United States on 2012-08-20
Patient: 71 year old male, weighing 63.0 kg (138.6 pounds)
Reactions: Diarrhoea, Haemorrhage Intracranial, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-08-03
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-08-03
Other drugs received by patient: Laxatives
Possible Velcade side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Nausea, Pain, Motor Dysfunction, Rash, Peripheral Sensory Neuropathy, Fatigue, Blood Potassium Decreased, Dyspepsia, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Cyclophosphamide
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Doxorubicin HCL
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Indication: Lymphoma
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Doxorubicin HCL
Dosage: on day 1
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Doxorubicin HCL
Dosage: on day 1
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Indication: B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Indication: Waldenstrom's Macroglobulinaemia
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphoma
Prednisone TAB
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphocytic Lymphoma
Rituximab
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Rituximab
Dosage: on day 1
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Rituximab
Dosage: maintenance
Indication: Lymphocytic Lymphoma
Rituximab
Dosage: maintenance
Indication: B-Cell Lymphoma
Rituximab
Dosage: on day 1
Rituximab
Dosage: maintenance
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: on day 1
Rituximab
Dosage: maintenance
Rituximab
Dosage: maintenance
Indication: Lymphoma
Rituximab
Dosage: on day 1
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: B-Cell Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Waldenstrom's Macroglobulinaemia
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: Lymphocytic Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Waldenstrom's Macroglobulinaemia
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: B-Cell Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphocytic Lymphoma
Other drugs received by patient: Acetaminophen; Diphenhydramine Hydrochloride; Ondansetron
Possible Velcade side effects in 4 year old female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)
Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk, cyclic
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-07-05
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-25
Possible Velcade side effects in
Reported by a physician from France on 2012-08-15
Patient:
Reactions: Diarrhoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1672 mg, unk
Indication: Multiple Myeloma
Start date: 2012-06-08
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-08
Velcade
Dosage: 2899 unk, unk
Indication: Multiple Myeloma
Start date: 2012-06-08
Other drugs received by patient: Valaciclovir; Esomeprazole; Atovaquone; Phenoxymethylpenicillin; Sodium Bicarbonate; Allopurinol
Possible Velcade side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient:
Reactions: Neuropathy Peripheral, Diarrhoea
Drug(s) suspected as cause:
Revlimid
Velcade
Indication: Multiple Myeloma
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male
Reactions: Diarrhoea
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-08-10
Patient:
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin Hydrochloride
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Gabapentin; Amoxicillin; Furosemide; Acetaminophen; Furosemide; Enoxaparin Sodium
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-08-10
Patient:
Reactions: Diarrhoea, Anaemia, Dizziness, Pulmonary Mycosis, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-08
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Velcade
Dosage: 2.6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Other drugs received by patient: Prednisolone; Tramadol HCL; Chlorhexidine Gluconate; Omeprazole; Itraconazole; Acyclovir; Symbicort; Montelukast; Cetraben / 01561901 /; Fluconazole; Nitrofurantoin; Citalopram Hydrobromide; NEO-Mercazole TAB; Cotrim; Ferrous Fumarate; Ventolin; Enoxaparin Sodium; Metoclopramide
Possible Velcade side effects in
Reported by a physician from Finland on 2012-08-06
Patient:
Reactions: Diarrhoea, Orthostatic Hypotension, Thrombotic Thrombocytopenic Purpura, Haemolytic Uraemic Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.0 mg/m2, cyclic
Possible Velcade side effects in 55 year old male
Reported by a physician from United Kingdom on 2012-08-02
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Decadron Phosphate
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin Hydrochloride
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Gabapentin; Acetaminophen; Amoxicillin; Enoxaparin Sodium; Furosemide
Possible Velcade side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Nausea, Motor Dysfunction, Pain, Rash, Peripheral Sensory Neuropathy, Fatigue, Dyspepsia, Blood Potassium Decreased, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Cyclophosphamide
Dosage: on day 1
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Cyclophosphamide
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Waldenstrom's Macroglobulinaemia
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Doxorubicin Hydrochloride
Dosage: on day 1
Doxorubicin Hydrochloride
Dosage: on day 1
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: B-Cell Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Waldenstrom's Macroglobulinaemia
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: Lymphocytic Lymphoma
Prednisone
Dosage: on days 1-5
Administration route: Oral
Prednisone
Dosage: on days 1-5
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Indication: Waldenstrom's Macroglobulinaemia
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphocytic Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Rituximab
Dosage: on day 1
Indication: B-Cell Lymphoma
Rituximab
Dosage: on day 1
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Indication: Lymphoma
Rituximab
Dosage: maintenance
Rituximab
Dosage: on day 1
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: non-Hodgkin's Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: B-Cell Lymphoma
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Indication: Lymphocytic Lymphoma
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: for every 6 months for 2 years or till progressive disease (maintenance)
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Indication: Waldenstrom's Macroglobulinaemia
Velcade
Dosage: 1.0 to 1.6 mg/m2 on days 1 and 8
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Waldenstrom's Macroglobulinaemia
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphocytic Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: B-Cell Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: on day 1 not to exceed 1.5 mg from level 1 and 2 and not to exceed 2 mg for level 3
Indication: Lymphoma
Other drugs received by patient: Diphenhydramine HCL; Acetaminophen; Ondansetron
Possible Velcade side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01
Patient:
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin Hydrochloride
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: 2.4 mg/m2, qd
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Acetaminophen; Amoxicillin; Furosemide; Furosemide
Possible Velcade side effects in
Reported by a physician from Netherlands on 2012-07-30
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Velcade side effects in 4 year old female
Reported by a consumer/non-health professional from United States on 2012-07-24
Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)
Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Diarrhoea, Ileus, Cardiac Failure, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-26
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-25
Possible Velcade side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Hyperaesthesia, Diarrhoea, Nausea, Haemoglobin Abnormal, Immunosuppressant Drug Level Increased, Blood Creatinine Increased, Micturition Urgency
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mycophenolate Mofetil
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-12-15
Prednisone
Dosage: 5 mg, cyclic
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-12-15
Rituximab
Dosage: 314 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-20
End date: 2011-10-20
Tacrolimus
Dosage: 12 mg, cyclic
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-10-21
End date: 2011-12-15
Thymoglobulin
Dosage: 100 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-10-25
Velcade
Dosage: 2 mg, cyclic
Indication: Renal Transplant
Start date: 2011-10-19
End date: 2011-10-29
Other drugs received by patient: Nystatin; Albuterol; Colace; Bactrim; Coreg; Vitamin D; Synthroid; Topamax; Vitamin B-12; Miralax / 00754501 /; Percocet; Valcyte; Pepcid; Plaquenil
Possible Velcade side effects in 76 year old male
Reported by a physician from France on 2012-07-19
Patient: 76 year old male, weighing 108.0 kg (237.6 pounds)
Reactions: Systemic Candida, General Physical Condition Abnormal, Pneumonia, Culture Stool Positive, Generalised Oedema, Renal Failure, Diarrhoea, Immunosuppression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone TAB
Dosage: 40 mg, oral
Administration route: Oral
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-06
Doxorubicin HCL
Dosage: 40 mg, intravenous
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-06
Rituximab (Rituximab) Suspension FOR Injection
Dosage: 857 mg, intravenous
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-03
Velcade
Dosage: 2 mg, intravenous
Indication: Mantle Cell Lymphoma
Start date: 2008-11-03
End date: 2008-11-03
Possible Velcade side effects in
Reported by a consumer/non-health professional from United Kingdom on 2012-07-19
Patient:
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Decadron
Dosage: 160 mg, qm
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, qd
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, qm
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, qd
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Amoxicillin; Furosemide; Furosemide; Enoxaparin Sodium; Acetaminophen; Gabapentin
Possible Velcade side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Velcade side effects in 55 year old male
Reported by a physician from United Kingdom on 2012-07-16
Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, qmo
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, qmo
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg/h, qmo
Indication: Multiple Myeloma
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Start date: 2010-10-18
End date: 2010-11-10
Velcade
Indication: Multiple Myeloma
Start date: 2010-09-27
Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium
Possible Velcade side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient: 69 year old female
Reactions: Injection Site Discolouration, Vomiting, Diarrhoea, Muscle Spasms
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13
Patient:
Reactions: Diarrhoea, Multiple Myeloma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Start date: 2010-10-18
End date: 2010-11-09
Dexamethasone
Dosage: 160 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Dosage: 64 mg, unknown
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Dosage: 64 mg, unknown
Indication: Polyuria
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: 2.4 mg/m2, unknown
Indication: Anti-Infective Therapy
Start date: 2010-09-27
Velcade
Dosage: 2.4 mg/m2, unknown
Start date: 2010-10-18
End date: 2010-11-09
Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: female
Reactions: Death, Neuropathy Peripheral, Fatigue, Diarrhoea, Colitis Microscopic
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Revlimid
Dosage: 25 mg, qd
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-04-01
End date: 2010-12-01
Revlimid
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2011-01-01
End date: 2011-03-01
Velcade
Dosage: 2.4 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2009-12-01
End date: 2010-09-01
Other drugs received by patient: Aredia; Dexamethasone Sodium Posphate
Possible Velcade side effects in
Reported by a physician from Netherlands on 2012-07-12
Patient:
Reactions: Diarrhoea, Pyrexia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-11
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-15
Velcade
Dosage: 2.6 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-04
End date: 2012-05-14
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-06
Patient: 55 year old male
Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Administration route: Oral
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Phosphate
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Start date: 2010-09-27
End date: 2010-10-17
Velcade
Dosage: dose unit:unknown
Start date: 2010-09-27
Velcade
Dosage: dose unit:unknown
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Gabapentin; Acetaminophen; Melphalan Hydrochloride; Thalidomide; Furosemide; Dexamethasone Sodium Phosphate; Furosemide; Cyclophosphamide; Amoxicillin; Cyclophosphamide; Enoxaparin Sodium
Possible Velcade side effects in
Reported by a pharmacist from Netherlands on 2012-07-06
Patient:
Reactions: Diarrhoea, Oliguria, Colitis, Pyrexia, Thrombocytopenia, Leukopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Valaciclovir; Cyclophosphamide; Fluconazole; Cotrim; Dexamethasone
Possible Velcade side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-05
Patient: male
Reactions: Fatigue, Neuropathy Peripheral, Diarrhoea, Dizziness, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in 4 year old female
Reported by a consumer/non-health professional from United States on 2012-07-05
Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)
Reactions: Hypophosphataemia, Left Ventricular Dysfunction, Diarrhoea, Hyponatraemia, Acute Respiratory Distress Syndrome, Hypocalcaemia, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-26
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-25
Possible Velcade side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-04
Patient: 55 year old male
Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Administration route: Oral
Start date: 2010-09-27
End date: 2010-10-17
Dexamethasone Sodium Phosphate
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Doxorubicin HCL
Start date: 2010-09-27
End date: 2010-10-17
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-09
Velcade
Dosage: dose unit:unknown
Start date: 2010-09-27
Velcade
Dosage: dose unit:unknown
Indication: Multiple Myeloma
Start date: 2010-10-18
End date: 2010-11-10
Other drugs received by patient: Enoxaparin Sodium; Amoxicillin; Dexamethasone Sodium Phosphate; Melphalan Hydrochloride; Cyclophosphamide; Thalidomide; Gabapentin; Acetaminophen
Page 1 Next >>
|
